anti-BCMA CAR-T Clinical Trials
5 recruitingBiologic
Phase 25
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia
Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT05870917
Recruiting
Phase 2
A Study of VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53 Abnormalities
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT05850286
Recruiting
Phase 2
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia
Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT05979363
Recruiting
Phase 2
BCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple Myeloma
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China80 enrolled1 locationNCT06793449
Recruiting
Phase 2
BCMA CAR-T Cell Therapy in High-risk NDMM Patients With Positive MRD After First-line ASCT
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT05846737